openPR Logo
Press release

Stroke Prevention Devices Market: : Premium Analysis and Global Growth Upto 2027

08-10-2017 03:38 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Stroke Prevention Devices Market: : Premium Analysis and Global

Stroke is a medical condition occurs due to interrupted blood supply to the brain, due to blockage of blood vessels which can lead to the death or death of brain cells. Because stroke takes place rapidly and immediate treatment requirement, it’s also called a brain attack. Being one of the major reasons of death worldwide, Stroke have high prevalence in the geriatric population. According to the WHO, stroke causes around 17 million deaths annually. As per CDC-The Center for Disease Control and Prevention, stroke causes 1 out of every 20 deaths fetching around USD 34 billion per year in the U.S. Hence, early diagnosis and treatment to prevent deaths from stroke is needed. Stroke prevention devices are used to reduction in risk of recurrent stroke in the patients. Stroke prevention devices have shown to lower the risk of stroke. Some stroke prevention devices are shown effectiveness as warfarin alternatives, enabling patients to stop taking warfarin after 45 days post implantation.

Read the Comprehensive Overview of Stroke Prevention Devices Market: http://www.transparencymarketresearch.com/stroke-prevention-devices-market.html

Stroke Prevention Devices Market: Drivers and Restraints

Stroke Prevention Devices Market have been surged by the increasing stroke patient pool along with rising geriatric population across the globe. Moreover, rise in the number of the aging population in western countries especially in Europe is the one of the key driving factor for surging the growth of stroke prevention devices market. Furthermore, atrial fibrillation, hypertension, and CHD-coronary heart diseases are the influencing factors promoting the growth of Stroke Prevention Devices Market. However, the high cost of devices directly affects the growth of Stroke Prevention Devices Market. Also, lack of supportive reimbursement scenario is also likely to impact the Stroke Prevention Devices Market. Nonetheless, new research and development in the healthcare sector and new emerging technologies are anteceded to start growth opportunities for the Stroke Prevention Devices Market over the years.

Stroke Prevention Devices Market: Segmentation

Stroke Prevention Devices Market has been segmented on the basis of Product, end user, and region

Based on Product, the stroke prevention devices market is segmented into the following:

Left Atrial Appendage Closure Devices
Patent Foramen Ovale (PFO) Closure Devices

Based on Product, the stroke prevention devices market is segmented into the following:

Hospitals
Ambulatory Surgical Centers
Others

Stroke Prevention Devices Market: Overview

Stroke prevention devices market is emerging owing to promising discovery of new innovative products. Key players in market are focusing on new technologies to reduce the risk of stroke and provide maximum safety to the patients. Also surge in the heart related disorders anticipates the robust growth in stroke prevention devices market .The global Stroke prevention devices market is expected to expand at healthy CAGR owing to increasing awareness for prevention of ischemic cerebral strokes across the world. Growing incidences of acute ischemic strokes among population is forecasted to surge the demand for stroke prevention devices market.

Stroke Prevention Devices Market: Region-wise Outlook

Geographically, Stroke Prevention Devices Market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, Middle East and Africa. North America and Europe regions are anticipated to cause maximum market revenue share in Stroke Prevention Devices Market over the forecast period due to availability of advanced healthcare infrastructure and presence of key players in the regions which are expected to hike the demand for Stroke Prevention Devices Market during the forecast period in the mentioned region. Asia Pacific region as well, is anticipated to witness slow growth due to high cost of the devices, and availability of economic alternatives like warfarin treatment.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25973

Stroke Prevention Devices Market: Key Players

The players leading in Stroke Prevention Devices Market include Abbott, AtriCure Inc., Coherex Medical, Boston Scientific Corporation to name a few.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stroke Prevention Devices Market: : Premium Analysis and Global Growth Upto 2027 here

News-ID: 664730 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Stroke

Global Stroke Imagine Processing Software Market 2021 | Increasing Number of Str …
Stroke Imagine Processing Software Market Snapshot Global Stroke Imagine Processing Software Market 2021 debates the report moreover centers around global giant manufacturers of the Stroke Imagine Processing Software with dynamic information like company profiles, market segmentation statistics, demanding situations and limitations, industry value, cost, sales, income, and much more information. This study provides key facts at the state of the industry and is a valuable supply of steerage and path for
Stroke Management Market Size To Reach USD 36.75 Billion, Globally, By 2023 | Di …
Asia-Pacific is expected to grow with the highest market share during the analysis period and would provide high opportunities for the market players. The global stroke management market was valued at $22,581 million in 2016, and is estimated to reach $36,756 million by 2023, growing at a CAGR of 7.1% from 2017 to 2023. The diagnostics segment held more than five-seventh share of the total market in 2016. Download Free Report Sample
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Atrial Fibrillation Stroke Treatment Market Segmentation By Atrial Fibrillation …
The arrhythmia problem occurs due to irregular heartbeats which can cause atrial fibrillation stoke. The irregular manner (increase pattern or lower pattern of heart beats) of heart beating pattern can cause atrial fibrillation stroke. The atrial fibrillation stroke causes major problem of heart and increase heart related problem. The patient which are suffering from atrial fibrillation effect two chamber of heart and atria present below the heart will lead to
Ischemic Stroke Market Stoking High at a CAGR of 8.3% - Stroke Statistics, Young …
Detail Analysis of “Global Ischemic strokes Market” with respect to region specific market growth and competitive analysis on the basis of major players present in the market. The study also provides a comprehensive review of restraints, market dynamics and drivers. – Outlet till 2023 Key Players for Global Ischemic strokes Market: The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the
Stroke Management Market By Application Ischemic Stroke and Hemorrhagic Stroke
The advancements in technology and facilities to diagnose stroke and discovery of novel drugs will drive growth of stroke management market. Technologies such as robotic-assisted angiography or exoskeleton soft suit for rehabilitation are the upcoming future of stroke management market. Moreover, an idea of Mobile Stroke Treatment Units (MSTU) was introduced in Germany in 2003 and was used in Berlin for the first time in 2008. The Prehospital Acute Neurological